Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Auditory Brain-Computer Interface (BCI) Algorithm Development

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract aims to develop advanced auditory brain-computer interface algorithms capable of decoding neural signals to accurately identify intended speech and reconstruct missing auditory information with minimal latency and without requiring frequent recalibration. The focus is on creating personalized models that adapt to individual neural patterns, ensuring high fidelity in speech decoding and auditory restoration for users with communication impairments. Success hinges on achieving real-time performance, robustness across varying neural states, and sustained accuracy without relying on extensive user retraining or system adjustments. The effort is being pursued as a subcontract under the Advanced Research Projects Agency for Health, part of the Department of Health and Human Services, with a North American Industry Classification System code of 541721 for research and development in the life sciences. The opportunity was posted on May 8, 2026, and proposals are due by August 14, 2026, at 6:00 PM Eastern Time. Performance is expected to center in Washington, though no specific location beyond the city is specified. The project targets breakthroughs in neural decoding technology to support next-generation assistive communication systems, prioritizing innovation in algorithmic personalization, speed, and reliability under real-world conditions.

General Info

Develop personalized auditory BCI algorithms to decode speech intent with low latency, minimal recalibration.

Agency

Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-h)View Agency

NAICS

541721

Place of Performance

Washington, DC, USA

Set-Aside

NONE

Documents

This scope was carved out of ARPA-H-SN-26-154.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy (HEARING) - Proposers' Day

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-h)
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-h)
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Develop personalized BCI algorithms that decode neural signals to identify intended speech and reconstruct missing auditory information with low latency and minimal recalibration.

Similar Contracts

Same NAICS industry code

NAICS: 541721
Grant
Formal Methods Software DevelopmentThe contract seeks the design and implementation of formally verified, secure software systems using rigorous mathematical techniques such as theorem proving, model checking, and formal methods to eliminate software vulnerabilities at their foundational level. The work demands the application of provable correctness to ensure systems meet strict security and reliability standards, with an emphasis on eradicating bugs and exploits before deployment. This effort requires deep expertise in formal verification methodologies, programming language theory, and secure system architecture to deliver software whose behavior can be mathematically guaranteed under all conditions. The contract is categorized as a subcontract under NAICS code 541721 and is issued by DARPA’s Information Processing Technologies Office within the Department of Defense. The opportunity is open for responses until June 22, 2027, and is not subject to any specific set-aside classification. There are no specified location constraints for performance, and no point of contact is provided. Interested parties must align their technical approach with the goal of achieving unassailable security through formal proofs rather than conventional testing or analysis, positioning this as a high-stakes development initiative aimed at advancing the state of secure computing infrastructure.
Darpa - Information Processing Technologies Office

POSTED

about 2 months ago

DEADLINE

in 10 months
View Details

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-h)

Same awarding agency

NAICS: 325412
Federal
Pharmaceutical Supply and Dosing Strategy SupportThe contract pertains to the formulation, stability testing, and supply chain management of ibogaine or closely related compounds under an Investigational New Drug application to support clinical research initiatives. It requires the secure and compliant production of precise dosing formulations, adherence to rigorous pharmaceutical standards for compound stability, and robust logistics to ensure uninterrupted delivery of materials to authorized research sites. All activities must align with federal regulatory requirements governing investigational substances and be executed within a tightly controlled framework to maintain quality, safety, and chain-of-custody integrity throughout the supply lifecycle. The work is being solicited as a subcontract under the Advanced Research Projects Agency for Health, a division of the Department of Health and Human Services, with a primary focus on accelerating innovative therapeutic development. The solicitation is open for responses until October 15, 2026, and the North American Industry Classification System code 325412 indicates the scope involves pharmaceutical preparations manufacturing. Performance is expected to meet stringent federal standards for investigational drug supply, with no geographical restrictions specified on place of performance, allowing for flexible, secure, and scalable logistical execution across approved facilities.
Pharmaceutical Preparation Manufacturing

POSTED

7 days ago

DEADLINE

in 2 months
View Details
NAICS: 541611
Federal
Operational Execution of Multi-Site Clinical TrialsThe contract titled Operational Execution of Multi-Site Clinical Trials entails the comprehensive management and coordination of clinical trial operations across multiple geographic locations, with core responsibilities including the training and oversight of clinical staff, the implementation of patient recruitment strategies, and the accurate and timely collection of trial data. The scope demands a robust operational framework to ensure protocol adherence, regulatory compliance, and data integrity across all participating sites, requiring experienced personnel with demonstrated expertise in decentralized and multi-site clinical research environments. Issued as a subcontract under the Advanced Research Projects Agency for Health part of the Department of Health and Human Services, this opportunity is governed by NAICS code 541611 and requires proposals to be submitted by October 15, 2026. While the solicitation number and specific address details are not provided, performance is expected to occur across unspecified locations, indicating a nationwide or potentially international operational footprint. The contracting entity seeks entities capable of delivering scalable, efficient, and compliant clinical trial execution without direct oversight, emphasizing autonomy, quality control, and responsiveness in complex, distributed study settings.
Administrative Management and General Management Consulting Services

POSTED

7 days ago

DEADLINE

in 2 months
View Details
NAICS: 621399
Federal
Therapeutic Set and Setting Protocol DevelopmentThe contract seeks the development of a comprehensive therapeutic set and setting protocol for the administration of ibogaine, focusing on the design of a safe, supportive, and clinically rigorous environment that optimizes patient outcomes. This includes the creation of structured psychological support systems, detailed patient preparation procedures, and integrated post-treatment protocols to ensure continuity of care and long-term therapeutic benefit. The protocol must be grounded in evidence-based practices and tailored to address the unique physiological and psychological demands of ibogaine therapy, with an emphasis on harm reduction, informed consent, and ethical standards. The work is being procured as a subcontract under the Advanced Research Projects Agency for Health, part of the Department of Health and Human Services, with a submission deadline of October 15, 2026. The project falls under NAICS code 621399, reflecting its focus on specialized medical services involving non-traditional therapeutic modalities. While the place of performance and point of contact details are not specified, the initiative aims to advance clinical frameworks for psychedelic-assisted therapies and requires a multidisciplinary approach integrating medical, psychological, and environmental design elements. Success will depend on delivering a replicable, scalable model that meets federal standards for safety, efficacy, and patient-centered care.
Offices of All Other Miscellaneous Health Practitioners

POSTED

7 days ago

DEADLINE

in 2 months
View Details
NAICS: 541690
Federal
Clinical Trial Safety and Risk Mitigation PlanningThe contract pertains to the development of comprehensive safety protocols for ibogaine clinical trials, with a focus on mitigating risks associated with its use in therapeutic settings. Key components include the implementation of rigorous cardiotoxicity monitoring systems to detect and manage potential cardiac adverse events, detailed assessments of drug interactions to prevent harmful combinations, and the establishment of dose de-escalation strategies to ensure patient safety across varying treatment phases. These protocols are intended to support the responsible and scientifically sound advancement of ibogaine research, particularly in contexts where safety concerns have historically hindered clinical progress. This subcontract is issued under the auspices of the Advanced Research Projects Agency for Health, a division of the Department of Health and Human Services, reflecting a federal commitment to advancing innovative but high-risk therapeutic modalities. The work is to be completed in response to a solicitation posted on August 5, 2026, with proposals due by October 15, 2026. The NAICS code 541690 indicates the nature of the work involves other scientific and technical consulting services, aligning with the specialized expertise required for designing and validating complex clinical safety frameworks. The place of performance and point of contact details are unspecified, suggesting flexibility in execution location while maintaining strict adherence to federal safety and compliance standards.
Other Scientific and Technical Consulting Services

POSTED

7 days ago

DEADLINE

in 2 months
View Details
NAICS: 541711
Federal
Integrated Phase I/II Clinical Trial DesignThe contract seeks the design and protocol development for an integrated Phase I/II clinical trial to evaluate ibogaine as a potential treatment for opioid use disorder, focusing on safety, optimal dosing, and therapeutic efficacy. The effort requires a comprehensive clinical framework that seamlessly merges the objectives of Phase I, which prioritizes dose escalation and toxicity profiling, with those of Phase II, which assesses preliminary effectiveness in reducing opioid dependence and withdrawal symptoms. The protocol must adhere to rigorous scientific and regulatory standards, incorporating appropriate patient selection criteria, monitoring procedures, endpoints, and risk mitigation strategies for a substance with significant pharmacological and safety considerations. The work is being pursued as a subcontract under the Advanced Research Projects Agency for Health, part of the Department of Health and Human Services, with a NAICS code indicating research and development in the life sciences. The solicitation was posted on August 5, 2026, and responses are due by October 15, 2026. The project is situated within a broader initiative to advance novel therapeutic interventions for the opioid crisis, requiring innovative trial design that balances exploratory research with clinical feasibility. There is no specified set-aside designation or location restriction for performance, indicating flexibility in execution while emphasizing scientific merit and regulatory alignment as key evaluation criteria.
Research and Development in Biotechnology

POSTED

7 days ago

DEADLINE

in 2 months
View Details
NAICS: 541611
Federal
Regulatory Strategy and FDA Alignment ConsultingThe contract seeks specialized consulting services to develop and implement a regulatory strategy aligned with FDA quality assurance standards, ensuring that system outputs are positioned for successful approval or adoption under applicable regulatory pathways. The work focuses on providing expert guidance to navigate the complexities of federal regulatory requirements, with particular emphasis on health technology systems undergoing evaluation by the Food and Drug Administration. The contractor must demonstrate a deep understanding of FDA processes, including validation, documentation, and compliance frameworks, to support the development of defensible, scalable, and FDA-ready solutions. This subcontract is issued by the Advanced Research Projects Agency for Health under the Department of Health and Human Services, with a place of performance in Washington DC, 20005. The opportunity is classified under NAICS code 541611 for management consulting services and is open for responses until August 20, 2026. While no specific set-aside designation is provided, the solicitation is structured to attract qualified entities capable of delivering strategic regulatory advisory services to federal health innovation initiatives. The contract aims to accelerate the translation of advanced health technologies into clinically adopted solutions by embedding regulatory compliance early and systematically into the development lifecycle.
Administrative Management and General Management Consulting Services

POSTED

15 days ago

DEADLINE

in 8 days
View Details
NAICS: 541714
Federal
Multimodal Sensor Integration and Signal Fusion EngineeringThe contract seeks integration of multiple sensing modalities into a unified platform designed for real-time pharmaceutical inspection, emphasizing synchronized signal correlation and advanced noise reduction techniques. The project requires the engineering of a robust system capable of fusing data from diverse sensor types to enhance detection accuracy, reliability, and speed in identifying product defects or anomalies during manufacturing processes. Development must ensure temporal and spatial alignment of signals, adaptive filtering for environmental and operational interference, and seamless interoperability across hardware and software components to support continuous, high-fidelity monitoring. This subcontract, under NAICS code 541714 and sponsored by the Advanced Research Projects Agency for Health within the Department of Health and Human Services, targets innovation in sensor fusion technologies with a specific focus on quality assurance in pharmaceutical production. The place of performance is designated as Washington DC with a zip code of 20005, and proposals must be submitted by August 20, 2026. The initiative aims to advance detection capabilities beyond conventional single-sensor approaches, enabling next-generation inspection systems that meet stringent regulatory standards through data-driven, real-time analytics.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

15 days ago

DEADLINE

in 8 days
View Details
NAICS: 541715
Federal
AI/ML Models for Drug Composition VerificationThe contract seeks the development of advanced machine learning algorithms to non-invasively verify drug identity, detect contaminants, and identify substandard pharmaceutical formulations by analyzing multi-sensor data without requiring penetration of the container. This effort is focused on creating robust AI models capable of interpreting complex sensor inputs to ensure drug quality and safety, supporting regulatory and public health objectives through innovative, contactless analysis. The work must be completed within a strict timeline, with proposals due by August 20, 2026, and is classified as a subcontract under NAICS code 541715, indicating a focus on research and development in the physical, engineering, and life sciences. The contracting agency is the Advanced Research Projects Agency for Health, part of the U.S. Department of Health and Human Services, and the performance location is designated as Washington, D.C. with a ZIP code of 20005. While no set-aside provisions or specific point of contact are provided, the solicitation emphasizes technological innovation in pharmaceutical verification, targeting solutions that enhance supply chain integrity and public health outcomes. The absence of a solicitation number and detailed office address suggests this may be an internal or pre-solicitation notice, but the clear deadline and agency affiliation indicate active planning for future contracting actions.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

15 days ago

DEADLINE

in 8 days
View Details